Chargement en cours...
Synergistic antitumor efficacy by combining adriamycin with recombinant human endostatin in an osteosarcoma model
In the last 15 years, chemotherapy-based therapeutic regimens for the treatment of osteosarcoma have failed to demonstrate improved survival rates. Novel approaches, including targeted therapy and antiangiogenic therapy, may provide new methods for the treatment of osteosarcoma, one of the most dead...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
D.A. Spandidos
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3408098/ https://ncbi.nlm.nih.gov/pubmed/22866125 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2011.334 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|